The new antiretroviral "cocktails": is the stage set for HIV-positive women to benefit?

PubMedPublished 10 February 1998Open access

Sharon Walmsley

Citations1

TL;DR

The sociodemographic characteristics, health status, health care utilization, degree of satisfaction with medical care and psychosocial stressors of 110 HIVpositive women in BC are described to identify barriers that can prevent HIV-positive women from benefiting from new treatment advances.

Keywords

Immunology and MicrobiologyMedicine

SciencePrognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

2,705 Citations1996John W. Mellors, Charles R. Rinaldo +4 more

Plasma viral load was a better predictor of progression to AIDS and death than was the number of CD4+ T cells, and the risk of acquired immunodeficiency syndrome (AIDS) and death in study subjects was directly related to plasma viral load at study entry.

JAMAAntiretroviral Therapy for HIV Infection in 1998

1,016 Citations1998Charles C. J. Carpenter, Margaret A. Fischl +12 more

Accumulating data from clinical and pathogenesis studies continue to support early institution of potent antiretroviral therapy in patients with HIV infection, and increased complexity in HIV management requires ongoing monitoring of new data for optimal treatment of HIV infection.

JAMAAntiretroviral Therapy for HIV Infection in 1997

728 Citations1997Charles C. J. Carpenter

New data have provided a stronger rationale for earlier initiation of more aggressive therapy than previously recommended and reinforce the importance of careful selection of initial drug regimen for each patient for optimal long-term clinical benefit and adherence.

New England Journal of MedicinePhysicians' Experience with the Acquired Immunodeficiency Syndrome as a Factor in Patients' Survival

462 Citations1996Mari M. Kitahata, Thomas D. Koepsell +4 more

The experience of primary care physicians in the management of AIDS is significantly associated with survival among their patients.

View PDF

The LancetDecline in deaths from AIDS due to new antiretrovirals

377 Citations1997Robert S. Hogg, Michael V. O’Shaughnessy +5 more

There was a significant decline in programme mortality rates since the first quarter of 1994, and this decline coincides with the availability of lamivudine in the province through open access and with the expanded use of double combination antiretroviral therapy.

AIDSPotential factors affecting adherence with HIV therapy

330 Citations1997Supriya Mehta, Richard D. Moore +1 more

A greatly increased level and duration of suppression of HIV replication has become possible with the use of protease inhibitors in combination with nucleoside analogues as antiretroviral therapy.

ScienceThe Daunting Challenge of Keeping HIV Suppressed

55 Citations1997Jon Cohen

Emerging data about treatment failures sounded a discordant note that was hard to miss: While powerful new drug combinations are delaying disease and death, they have serious limitations and clinicians and patients who ignore these shortcomings do so at their peril.

PubMedHIV-positive women living in the metropolitan Toronto area: their experiences and perceptions related to HIV testing. The HIV Women's Study Group.

16 Citations1997Lois Jackson, Peggy Millson +6 more

The findings from this study suggest that encouraging individuals to be tested if they have engaged in “at risk” activities will not be appropriate for individuals who have no perception of risk, and other strategies to encourage appropriate testing may be needed.

PubMedPrevalence of HIV infection among pregnant women in Newfoundland.

13 Citations1996Samuel Ratnam, Katherine Hogan +1 more

This study provides an independent confirmation of an outbreak of HIV infection among women in the Eastern Health Region of the province and indicates there are an estimated 125 HIV-positive women of childbearing age in Newfoundland.